Current challenges and emerging opportunities of chimeric antigen receptor-engineered cell immunotherapy

Abstract Chimeric antigen receptor (CAR) engineered cellular immunotherapy offers the potential for precise targeting and elimination of tumor cells, providing a tailored approach to cancer treatment. CAR-T cells demonstrate significant anti-tumor activity among these therapies. Nonetheless, these t...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yong Liu, Yifei Duan, Zefan Du, Bo Lu, Su Liu, Lindi Li, Mengyao Tian, Liang Li, Ran Yao, Cheng Ouyang, Mo Yang, Chun Chen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-07-01
Edice:	Experimental Hematology & Oncology
Témata:	CAR-T CAR-NK CAR-M Immunotherapy Clinical application
On-line přístup:	https://doi.org/10.1186/s40164-025-00683-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!